Instrument Inactif

Autres langues AKOUOS

Actions

AKUS

US00973J1016

Recherche biotechnologique et médicale

Autres langues

23/01/24	Akouos, Inc. Announces Positive Initial Clinical Results from the Phase 1/2 AK-OTOF-101 Study
01/12/22	AKOUOS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)
01/12/22	Akouos, Inc. Announces Executive and Board Changes
01/12/22	Lilly Wraps Up Acquisition of Akouos
01/12/22	Akouos, Inc.(NasdaqGS:AKUS) dropped from NASDAQ Composite Index
01/12/22	Eli Lilly and Company completed the acquisition of Akouos, Inc. from a group of shareholders.
30/11/22	Eli Lilly's Buyout Offer Accepted by 81% Akouos Shareholders at Closing
30/11/22	Lilly and Akouos Announce Expiration of Akouos Tender Offer
30/11/22	Akouos, Inc.(NasdaqGS:AKUS) dropped from S&P TMI Index
29/11/22	Akouos, Inc.(NasdaqGS:AKUS) dropped from NASDAQ Biotechnology Index
14/11/22	Akouos Q3 Loss Narrows
14/11/22	AKOUOS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
14/11/22	Akouos, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
14/11/22	AKOUOS, INC. : Results of Operations and Financial Condition (form 8-K)
14/11/22	Akouos Reports Third Quarter 2022 Financial Results and Provides Business Highlights
19/10/22	AKOUOS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akouos, Inc. - AKUS
18/10/22	Wall Street sluit hoger
18/10/22	Health Care Up Amid Earnings, Deals -- Health Care Roundup
18/10/22	Wall Street houdt winst vast
18/10/22	Eli Lilly to Acquire Genetic Medicine Developer Akouos for up to $610 Million
18/10/22	MÄRKTE USA/Börsen setzen Erholung fort
18/10/22	Top Midday Gainers
18/10/22	Eli Lilly to Acquire Genetic Medicine Firm Akouos for Up to $610 Million
18/10/22	MÄRKTE USA/Rally an Wall Street verliert an Schwung
18/10/22	Aktien New York Ausblick: US-Börsen dürften Gewinne ausbauen